Rheumatoid Arthritis Drugs/Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2986 | Report Format : | Status : Upcoming |

Abstract

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Overview

Rheumatoid arthritis is basically an autoimmune, inflammatory syndrome that generally causes swelling, chronic pain, and loss in the running ability of joints. It majorly occurs when an individual immune system attacks the synovium; the internal lining of membranes which mainly surrounds or covers the joints. In several patients, these antibodies may also injure few body systems which comprise the heart, skin, eyes, blood vessels, and lungs. The occurrence of rheumatoid arthritis extensively varies in various geographic regions, the lowest rates is likely to experience in the Asian countries as well as higher rates amongst some American inhabitants.

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Growth Factors

Increasing prevalence of the syndrome, occurrence of biosimilars & biologics, and well-defined authoritarian guidelines are likely to offer a boost to the global rheumatoid arthritis drugs/therapeutics market. As per the Arthritis Foundation, around 65% of the population between the age group of 60-65 is projected to suffer from arthritis problem in the U.S. Growing knowledge regarding syndrome remittance therapies and increasing healthcare expenses particularly in developed regions are projected to promote revenue development. The major expansion growth drivers of the global rheumatoid arthritis drugs/therapeutic market comprise, augment in geriatric inhabitants which are more prone to rheumatoid arthritis, higher prevalence rates, and launch of novel therapeutic agents. On the other hand, aspects such as insufficient insurance coverage for few drugs in emerging countries, patent expiration of some blockbuster drugs and non-availability of the treatment are the major restraints and challenges for the global rheumatoid arthritis drugs/therapeutic market.

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Segmentation

The global rheumatoid arthritis drugs/therapeutics market can be classified in terms of sales channels, molecule types, and region. In terms of molecule, the global rheumatoid arthritis drugs/therapeutics market is categorized into pharmaceuticals and biopharmaceuticals. Pharmaceuticals division is further fragmented into analgesics, NSAIDs, DMARDs, and glucocorticoids. Biopharmaceuticals segment is bifurcated into biologics and biosimilars. In terms of sales channel, the global rheumatoid arthritis drugs/therapeutics market is bifurcated into over the counter (OTC) and prescription.

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Regional Analysis

North America is likely to account for a significant market share for the global rheumatoid arthritis therapeutics market. High awareness of syndrome remittance therapies amongst patients, increasing occurrence of RA, and high private and public healthcare investment are likely to stimulate the development of the region. In addition, easy access to better healthcare, strong clinical pipeline, favorable reimbursement policies, and support of novel drugs are anticipated to likely promote revenue expansion in North America.

Asia Pacific is projected to grow at the highest rate in the coming future. Rising acceptance of urban standard of living is likely to lead to the increasing base of patients in the province. Growing healthcare investments is projected to fuel the market growth in Asia Pacific. Favorable authoritarian policies for biosimilars are anticipated to propel the demand and popularity for the global rheumatoid arthritis drugs/therapeutics in the coming years.

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Competitive Players

Some of the most important market players in the global rheumatoid arthritis drugs/therapeutics market are Boehringer Ingelheim GmbH, AbbVie, Regeneron Pharmaceuticals, Inc., Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., UCB S.A., F. Hoffmann-La Roche Ltd., Amgen, Inc., and Johnson & Johnson Services, Inc., among others.

Global Rheumatoid Arthritis Drugs/Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Dental Imaging System Market by Dental Imaging Device Type (2D and 3D Imaging System), Product Type (Intraoral and Extra Oral Radiography System) and by End Users (Dental Clinics & Laboratories, Hospitals, and Dental Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2024

Jun-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3129 | Report Format:

The report covers forecast and analysis for the dental imaging system market on a global and regional level. The study provides historical data from 2016 along with forecast from 2018 2024 based on the revenue (USD Million). The study includes drivers and restraints for the dental imaging system ...Read More

Holter Monitor Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3120 | Report Format:

Global Holter Monitor Systems Market: Overview Holter monitoring systems attribute to portable a medical device which is used to monitor heart rhythms and requisite for recording, analyzing, diagnosing and communicating ECG data to healthcare professionals at any given time. Holter monitor consi...Read More

Glucose Tester Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3119 | Report Format:

Global Glucose Tester Market: Overview The most commonly occurring diseases including Diabetes have overpowered the rising global population. It is a condition which cannot be prevented completely but can be monitored and controlled to some extent. This is a point where the opportunity of this m...Read More

ENT Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3118 | Report Format:

Global ENT Devices Market: Overview ENT devices are special equipments used for diagnosis and treatment of disorders related to the ears, nose and throat. The wide range of ENT devices used are endoscopes, hearing aids, voice prosthetics, Otoscopes, tongue depressors, tonsil forceps, Laryngoscop...Read More

Gamma Knife Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3106 | Report Format:

Global Gamma Knife Market: Overview Gamma knife is a fine beam technology that is specifically designed to treat the tissues of the brain during radiosurgery. Apart from brain tissues, it also assists in treating trigeminal neuralgia and vascular malformations. This product with the advanced tec...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.